San Diego County Democrats for Environmental Action
  • Home
  • 2022 Endorsements
  • Join or Renew
    • Support
  • Announcements
  • About
    • Bylaws
    • 2020 Endorsements
  • Contact
  • Green Blog

Green Blog

Lack of Testing in COVID-19 Pandemic Lays Bare Basic Failure of Neoliberalism

3/22/2020

0 Comments

 
Picture
Testing for COVID-19 at the San Francisco Department of Public Health.
Picture
By Cody Petterson

My wife provides me with a steady stream of questions from her wide circle of moms, which has been sending me ever deeper into the internet in search of peer-reviewed answers. I've put my general understanding to paper here, and I'll edit this essay as necessary to reflect the resulting consensus.


As you've become aware over the last several weeks, COVID-19 is a serious, potentially deadly virus. Even young, healthy individuals without apparent underlying risk factors can experience severe and even fatal symptoms. Given our nation's scandalous lack of testing capability for this virus, the number of infected individuals is likely to dwarf lab-confirmed infections by an order of magnitude.

For every hospitalization, there are around three infections with moderate symptoms that don't meet the current criteria for testing, five infections with mild symptoms, and another two infections that are virtually asymptomatic. These are ballpark figures, but our catastrophic lack of testing means that the ratio of infections to lab-confirmed infections is somewhere around 10 to 1. Make no mistake: this virus is widespread in the United States. Many people you know will be hospitalized. Someone you know may die.


After a number of conversations with professionals in related fields, I'm convinced universal social isolation of even low-risk adults is currently sound policy, due in particular to our lack of testing, the gross inadequacy of our private, for-profit national healthcare system, and the likelihood that even if we were able to completely isolate and prevent infection of high-risk individuals, hospitalizations of low-risk individuals with severe symptoms would likely overwhelm our hospitals and devastate our healthcare providers.

Enabling Virus Growth and Transmission


All evidence I've seen suggests that COVID-19, though potentially severe and even fatal, is similar to other coronaviruses (MERS, SARS, OC43, 229E, etc.) in its clinical features. Transmission occurs overwhelmingly through airborne respiratory droplets, ejected through sneezing, coughing, heavy breathing, or speaking. Transmission from infected surfaces to hands and then to the face is possible, but not considered a major source of infection. Viral shedding occurs prior to the onset and after the cessation of symptoms, but most transmission appears to occur when individuals are symptomatic, as a direct result of talking, heavy breathing, and symptomatic coughing and sneezing.

You can do a simple search on the internet for symptoms. The most prominent are fever, dry cough, fatigue, sputum production, and shortness of breath. The incubation period is three to 11 days, with a median of five days. The median duration of illness from onset of symptoms to recovery is two weeks for mild cases, and three to six weeks for those with severe cases.You can do a simple search on the internet for symptoms.

Risk factors for severe illness and fatalities, particlarly for those over the age of 70, include immunodeficiency, cardiovascular disease, diabetes, hypertension, respiratory disease, cancer, obesity, asthma, and smoking. Men have higher infection, illness, and fatality rates than women, which is partly attributable to higher rates of smoking among men, but also apparently related to hormonal and other immunological differences.

Immune response appears to be normal, with a successful resolution of symptoms conferring immunity of undetermined duration. Immunity is a complex subject. The memory B cells that produce a particular antibody can last a lifetime, but the number of antibodies and the strength of immune response declines over time. Genuine viral exposure generally confers a stronger, more lasting immunity than vaccination. Other coronaviruses provide equivocal, incomplete data. MERS antibodies have been found to decline rapidly following resolution of symptoms, while SARS antibodies are detectable in the bloodstream more than a decade after exposure. I think it's safe to say a full exposure is likely to confer immunity for at least a year, but that's conjecture.

Some fatalities appear to be the result of Cytokine Storm Syndrome (CSS). This can occur in normal, healthy individuals, but is more common in those who are immunodeficient or have an inherited, though often previously unidentified, genetic or epigenetic predisposition. If you've ever been on the wrong end of poison oak you've experienced the severe tissue damage your immune system can inflict on you when pro-inflammatory cytokines tell your own macrophages to attack your cells. Now imagine that damage is in your lungs and other internal organs.

This is not, however, a common immunological response to the virus, though you are likely to read horror stories about it in the press. It turns out Buzzfeed doesn't run stories about 38 year-olds home from work playing Fortnite with a slight fever and intermittent dry cough.


The Virus is the Virus

The SARS-CoV-2 virus behind the COVID-19 pandemic in Italy is essentially identical to the one infecting South Korea, China, and the United States. Although tiny errors in transcription are constantly occurring, there aren't multiple functionally distinct strains. The mutation rate appears to be normal. According to the Fred Hutchinson Cancer Center in Seattle, "The mutation rate looks to be about 24 mutations per year. This rate of two mutations per month is similar to other RNA (ribonucleic acid) v
iruses like flu." None of the mutations identified thus far appear to be functionally significant.

Therefore, it follows that the apparent differences in mortality are not the result of changes in the virus, but rather different population structures, epidemiological baselines, cultures, healthcare systems, and government responses. High fatality rates in Italy are likely explained, in part, by its having one of the world's oldest populations. In the United States, our high rates of diabetes, obesity, and physical inactivity may ultimately contribute to higher fatality rates among younger patients.


It seems, however, that a key factor driving apparently differing rates of morbidity and fatality are the dramatically different levels of testing. Recent news coverage of the CDC's March 16th Morbidity and Mortality Weekly Report (MMWR) has, to my mind, been irresponsible in its characterization of the risk profile of the virus.

From its very beginnings in Wuhan, the majority of confirmed cases (77.8 percrent) were made up of 30 to 69 year olds. The percentage of relatively young infections is probably even higher, since symptoms in children, teenagers, and young adults appear in general to be mild, and it's likely many of their infections escaped confirmation (which, for the China CDC report, was diagnosed by "positive viral nucleic acid test results"). Furthermore, 80.9 percent of cases exhibited mild to moderate symptoms, which is likely a similar underestimate for the same reasons.

In South Korea, which has a robust testing and quarantine regimen, the case fatality rate has been 1.1 percent for males and .4 percent for females. Fatality rates from newborns to 30 were zero. Ages 30 to 39 were .1% (one fatality of 693 infected), 40 to 49 at .1% (one fatality of 889 infected), 50 to 59 .4% (five fatalities of 1,217 infected), and increasing up to a six percent case fatality rate for those 80 and over.

Some of this may reflect a national population that is generally healthier, as well as early detection and effective universal treatment, but it's very likely widespread testing of the population results in a more accurate picture of COVID-19's morbidity and fatality rates.
This presumption is strengthened by the case in Germany, which has an even more expansive testing regime and significantly lower rates of hospitalization and fatalities. By testing individuals who are asymptomatic or mildly symptomatic, countries like Germany and South Korea provide a much clearer picture of the risk profile of the virus.

The United States could not present a more extreme contrast. Because the U.S. has catastrophically failed to develop an effective testing program, relatively few individuals have been tested, and the pool of those tested is not representative of the total population of infected individuals.

As of March 16th, the end of the reporting period for the CDC MMWR, the U.S. had tested roughly 50,000 individuals. It has been widely reported that healthcare workers were and are rationing tests based on age, underlying conditions, recent international travel, and exposure to known COVID-positive individuals.

As a result, the U.S. infection sample is systematically excluding those who are asymptomatic, mildly symptomatic, and moderately symptomatic with no underlying risk — a group that, based on all prior evidence, is by far the majority of infected individuals. As a result, the March 16th MMWR's sample dramatically over-represents the most heavily impacted individuals.

Universal Testing is a Must


The lack of available testing doesn't just misrepresent the virus' impact, it's the fundamental flaw in the Trump Administration's response to the pandemic. If there is any justice in this world, that alone will end Trump’s hopes of re-election (unfortunately, the opposite is likely to occur, as anyone who remembers the bumps W. got from his own catastrophic failures can tell you). With adequate testing, travel restrictions, and targeted quarantines, the U.S. could have contained COVID-19 a month ago, and dramatically reduced what are likely to be thousands of fatalities and profound, long-term social, economic, and public health consequences.

The single most important public health priority needs to be nearly universal testing of symptomatic and asymptomatic individuals alike, and targeted quarantine of COVID-positive patients, regardless of symptoms.


Our for-profit private healthcare system is fundamentally unsuited and inadequate to respond to public health threats of this type and magnitude, and COVID-19 is a conclusive argument in favor of a national single payer healthcare system. In addition, COVID-19 isn't even close to a worst-case scenario. Imagine a slightly different virus that was even more communicable, like measles, or which had a longer incubation period, again like measles, or which was more fatal, like Ebola, or which disproportionately killed children, like the 1918 H1N1 flu.

One of the substantial advantages that nations of the East Pacific Rim have had in responding to COVID-19 is their recent, prior experience with SARS. As catastrophic as the COVID-19 pandemic is, it has given us the opportunity to prepare ourselves for future calamities.

We will continue to face crises like these, many of them aggravated by the climate emergency. What we need, right now, is:
  1. Informed, competent, wise elected leadership.
  2. Experienced, well-trained, well-funded, professional public administrators.
  3. Fiscal, trade, and monetary policies that foster broadly-shared prosperity that reduce rather than deepen inequality.
  4. Foster renewed national solidarity in revitalized democratic institutions and a recognition of our common fate.

Neoliberalism's long, decadent, sociopathic dream is over. This is a terrifying way to wake up, but it also provides an opportunity to reboot, and rebuild our nation as we prepare ourselves for the towering challenges the rest of this century is bound to bring.

Picture
Christopher Hall is a registered nurse on the front lines against the pandemic.

Top photo by Tyrone Jue / San Francisco Department of Public Health
Bottom photo by Michelle French / University Hospitals Portage Medical Center

0 Comments

March Club Meeting Cancelled

3/13/2020

0 Comments

 
Picture
Along the Eagle Rock trail, Cleveland National Forest near Warner Springs.
Picture
By Cody Petterson and Tommy Hough

Clearly we're in a highly unusual and unprecedented moment with the COVID-19 pandemic.

Since a state of emergency has been declared at the state, county, and local levels in which large gatherings of people have become ill-advised, we have cancelled the March meeting of
San Diego County Democrats for Environmental Action.

At this point, we are still planning on holding our April club meeting, scheduled for Wednesday, April 15, as usual at Elijah's. That meeting's program and slate of guests will be announced soon. Check back at our website and social media for more.

In the meantime, please elect to keep yourselves, your families, and loved ones safe. Check in on elderly or vulnerable neighbors and friends.

For up to date information, here are the websites for the County of San Diego and City of San Diego.

Please stay safe and in communication with family and friends. Let's look out for each other.


0 Comments

Strong Primary Showing for Environmental Democrats

3/7/2020

0 Comments

 
Picture
A sign directing voters to a polling location in southeast Mira Mesa.
Picture
By Tommy Hough

The first March primary in California history was a successful day for nearly all our San Diego County Democrats for Environmental Action endorsed candidates. According to the Registrar of Voters, some 60,000 votes remain to be counted.


  • Congressman Mike Levin (CA-49) won his first primary as an incumbent with a 58 to 41 percent decision over his GOP competitor, who he'll face again in the fall.

  • California Senate President pro tem Toni Atkins (SD-39) and Assemblymember Lorena Gonzalez (AD-80) both handily won their contests. Sen. Atkins had no primary challenger, while Assemblymember Gonzalez is dominating with a 71 percent finish over her two GOP challengers.

  • In his race for the 78th Assembly District seat being vacated by Todd Gloria, San Diego City Councilmember Chris Ward (D-3) earned 57 percent over his two competitors, both Democrats. Ward will face rival Democrat Sarah Davis in November.

  • Attorney and professor Terra Lawson-Remer won her primary and continues to consolidate her second place finish against GOP incumbent and Trump ally Kristen Gaspar in the all-important San Diego County Board of Supervisors District 3 (BOS-3) race.

  • Former mayor and incumbent Chula Vista District 3 city councilmember Steve Padilla, who also serves as chair of the California Coastal Commission, won a victory over his two GOP rivals with 55 percent of the vote, and will face a Republican challenger in the fall.

  • In San Diego City Council District 1 (D-1), Joe LaCava won his primary and continues to add votes to a strong first place finish in a crowded field to replace outgoing San Diego City Council President pro tem Barbara Bry. Joe will face Democrat Will Moore in November.

  • Previous council and county supervisor candidate Stephen Whitburn won his primary and continues to add onto an impressive first place finish in San Diego City Council District 3 (D-3) to replace outgoing councilmember Chris Ward. Stephen will face Democrat Toni Duran this fall.

  • Deputy city attorney Marni von Wilpert won her primary in San Diego City Council District 5 (D-5) with a back-and-forth nailbiter for first place over her GOP rival, who she will again face in the fall. District 5 is one of several council districts that have seen an increase in Democratic registration.

  • In San Diego City Council District 7 (D-7), another area that's seen a surge in Democratic registration, deputy city attorney Raul Campillo continues to add onto a solid first-place finish over a well-funded GOP opponent, who he will similarly face in the fall.

  • In the San Diego mayor's race, Assemblymember Todd Gloria (AD-78) continues to consolidate an exceedingly strong first place finish. Along with Todd, fellow Democrats Barbara Bry (D-1) and Tasha Williamson were rated qualified by the club, and Bry currently trails Republican councilmember Scott Sherman by 337 votes as they vie for a second place finish to compete against Todd in the fall.

  • As was the case with Lilac Hills in 2016, San Diego County voters made it clear they're tired of destructive sprawl development, especially zombie projects like Measure B, the initiative to build the Newland Sierra development at the site of the former Merriam Mountains proposal. Measure B was soundly defeated with 58 percent of the vote.

Unfortunately, two of our endorsed candidates and one of our endorsed ballot measures have come up short.

  • Port of San Diego Commissioner and founding club member Rafael Castellanos has conceded in the race for San Diego County Board of Supervisors District 1 (BOS-1) in a close loss to former Planned Parenthood of the Pacific Southwest vice president Nora Vargas. All Democrats, Nora will face Sen. Ben Hueso in the general election.

  • Marriage therapist and behavioral health specialist Kenya Taylor placed third in her Board of Supervisors District 2 (BOS-2) effort behind her two GOP rivals. As is the case with Rafael, we're disappointed Kenya won't move on to November, but we thank her for her campaign and advocacy, and we were proud to endorse her.

  • Despite one of the most impressive environmental, labor, and community coalitions assembled in recent years, Measure A, i.e. the Save Our San Diego Countryside (SOS) initiative, succumbed to an extraordinary assault of money from realtors and developers, as well as the BIA, and has been defeated. After a brief lead, Measure A fell behind and was never able to recover ground.

Picture
An egret at Kendall-Frost Marsh Reserve along Mission Bay, Pacific Beach.

Photos by Tommy Hough and Greg Hoxsie.
0 Comments

    Green Thoughts

    The blog component of San Diego County Democrats for Environmental Action welcomes content from SDCDEA members, guests and leadership.

    Archives

    December 2022
    September 2021
    August 2021
    July 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    September 2019
    August 2019
    July 2019
    May 2019
    April 2019
    March 2019
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    June 2017
    April 2017
    February 2017
    January 2017
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    April 2016
    February 2016
    January 2016
    November 2015
    October 2015
    September 2015
    June 2015
    April 2015
    January 2015
    November 2014
    September 2014

     Categories

    All
    Hiking
    Southern California
    Tommy Hough

    RSS Feed

Picture
Picture

Social Media

Quick Links

       Home
       About
       Join
       Bylaws
       Contact
       Green Blog
  • Home
  • 2022 Endorsements
  • Join or Renew
    • Support
  • Announcements
  • About
    • Bylaws
    • 2020 Endorsements
  • Contact
  • Green Blog